Tech Company Financing Transactions
Solve Therapeutics Funding Round
Yosemite, Abingworth and Alexandria Venture Investments participated in a $120 million venture round for Solve Therapeutics. This venture round was announced on 11/17/2025.
Transaction Overview
Company Name
Announced On
11/17/2025
Transaction Type
Venture Equity
Amount
$120,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its clinical pipeline and proprietary CloakLink� linker platform. The new funding will support the completion of Phase 1b studies for both programs and expand its operational capabilities as it advances toward later-stage clinical development.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Undisclosed
San Diego, CA Undisclosed
USA
San Diego, CA Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Solve is developing novel antibody-drug conjugates (ADCs) with high selectivity and optimized payload delivery enabled by CloakLink�, our proprietary hydrophilic linker system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Dave Johnson
Browse more venture capital transactions:
Prev: 11/17/2025: Gridware venture capital transaction
Next: 11/18/2025: PicoJool venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs